Cardiovascular 1
Treatment of atrial myxoma
Surgical excision
Most common cause of HFpEF
Hypertension
Most effective drug therapy for hypertriglyceridemia
Fenofibrate
TTE surveillance frequency in asymptomatic HCM
Every 1-2 years
Primary CV side effect of bevacizumab
Hypertension
Physical findings in chronic mitral regurgitation
Blowing holosystolic murmur, systolic click, S3, lateral displacement of apical impulse
Alternative treatment for patients with HFrEF intolerant of ACE inhibitors or ARBs
Isosorbide dinitrate-hydralazine
Aortic atheroma treatment
Antiplatelet agent and statin
Management of TAA with diameter <5.0 cm
β-Blockers with target BP <130/80 mm Hg
Recommended heart valve type for patients older than 65 years
Bioprosthesis
Treatment of recurrent or chronic pericarditis with a noninflammatory phenotype
Glucocorticoids
Most common ECG findings in HCM
Increased QRS voltage, left atrial enlargement, LV conduction abnormalities, pathologic Q waves, repolarization abnormalities
Criteria for adding to maximal statin therapy in secondary ASCVD prevention in patients not considered at very high risk
LDL cholesterol level ≥70 mg/dL or <50% reduction in LDL
RV failure, normal BNP, pericardial thickening
Constrictive pericarditis
Complication if ACE inhibitor is discontinued <36 hours before valsartan-sacubitril is started
Angioedema
Treatment of acute pericarditis
NSAIDs plus colchicine
Cardiomyopathy associated with apical dyskinesis or ballooning
Takotsubo (stress) cardiomyopathy
Duration of DAPT after ACS
At least 12 months
Diagnostic criteria for acute pericarditis
Pleuritic chest pain plus one of the following: pericardial friction rub, new ECG changes, new effusion, inflammatory biomarker elevation, imaging indicative of pericardial inflammation
Fever, myalgia, and respiratory symptoms followed by HF
Viral myocarditis
Cardiac biomarker to distinguish restrictive cardiomyopathy (elevated) from constrictive pericarditis (normal)
BNP
Drugs indicated for all NYHA functional classes of HFrEF
β-Blockers, specifically bisoprolol, carvedilol, or metoprolol succinate, and ACE inhibitors
Syndrome of angina and normal coronary arteries
Cardiac syndrome X (microvascular angina)
Baseline ECG abnormalities that warrant imaging along with stress testing
ST segment depression, LVH, LBBB, digitalis effect, preexcitation, paced beats
Life-prolonging therapy for severe aortic stenosis
Aortic valve replacement